de Vries, M., Mohamed, A. S., Prescott, R. A., Valero-Jimenez, A. M., Desvignes, L., O’Connor, R., . . . Dittmann, M. (2021). A comparative analysis of SARS-CoV-2 antivirals in human airway models characterizes 3CL(pro) inhibitor PF-00835231 as a potential new treatment for COVID-19. bioRxiv.
Citação norma Chicagode Vries, Maren, et al. "A Comparative Analysis of SARS-CoV-2 Antivirals in Human Airway Models Characterizes 3CL(pro) Inhibitor PF-00835231 As a Potential New Treatment for COVID-19." BioRxiv 2021.
Citação norma MLAde Vries, Maren, et al. "A Comparative Analysis of SARS-CoV-2 Antivirals in Human Airway Models Characterizes 3CL(pro) Inhibitor PF-00835231 As a Potential New Treatment for COVID-19." BioRxiv 2021.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.